Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GFREE - A Study for Improved Blood Sugar Levels, Reduced Inflammation and for Increasing Knowledge of the Connection Between Diabetes and COVID-19.

NCT05894746 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT05894746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05894746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GFREE - A Study for Improved Blood Sugar Levels, Reduced Inflammation and for Increasing Knowledge of the Connection Between Diabetes and COVID-19.
Lead sponsor
Göteborg University
Phase
Not applicable
Overall status
Recruiting
Start date
May 4, 2023
Completion date
December 31, 2030
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmunity, celiac disease, diabetes, metabolic disease